Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;19(1):151-168.
doi: 10.1111/ddg.14371.

Update "Systemic treatment of atopic dermatitis" of the S2k-guideline on atopic dermatitis

Thomas Werfel  1 , Annice Heratizadeh  1 , Werner Aberer  2 , Frank Ahrens  3 , Matthias Augustin  4 , Tilo Biedermann  5 , Thomas Diepgen  6 , Regina Fölster-Holst  7 , Julia Kahle  8 , Alexander Kapp  1 , Katja Nemat  9 , Eva Peters  10 , Martin Schlaeger  11 , Peter Schmid-Grendelmeier  12 , Jochen Schmitt  13 , Thomas Schwennesen  14 , Doris Staab  15 , Claudia Traidl-Hoffmann  16 , Ricardo Werner  17 , Andreas Wollenberg  18 , Margitta Worm  19 , Hagen Ott  20
Affiliations
Free article

Update "Systemic treatment of atopic dermatitis" of the S2k-guideline on atopic dermatitis

Thomas Werfel et al. J Dtsch Dermatol Ges. 2021 Jan.
Free article

Abstract

This guideline is an update from August 2020 the S2k-guideline "Atopic dermatitis" published in 2015. The reason for updating this chapter of the guideline were the current developments in the field of systemic therapy of atopic dermatitis. The agreed recommendations for systemic treatment in atopic dermatitis of the present guideline are based on current scientific data. Due to the approval of dupilumab for the treatment of moderate to severe atopic dermatitis, which cannot be treated sufficiently with topical drugs alone, this part of the guideline has now been adapted and newly consented. The indication for systemic therapy and the therapeutic response to topical and systemic treatment should be recorded and documented in a suitable form in clinic and practice. A standardized documentation of the indication for system therapy in atopic dermatitis can be recommended and is also part of the updated chapter of this guideline.

PubMed Disclaimer

References

    1. Werfel T, Heratizadeh A, Aberer W et al. Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]. J Dtsch Dermatol Ges 2016; 14: e1-e75.
    1. Werfel T, Aberer W, Ahrens F et al. S2k Leitlinie Neurodermitis. AWMF online: AWMF Leitlinienregister Nr. 013/027. 2015.
    1. Augustin M, Werfel T, vonKiedrowski R. Checkliste: Indikationsstellung zur Systemtherapie der Neurodermitis bei Erwachsenen. 2018. Available from: https://www.teledermatologikum.de/wp-content/uploads/AtopiTool-Checklist..., 2018 [Last accessed September 16, 2020].
    1. Fachinformation Dupixent 300 mg Injektionslösung in einer Fertigspritze. Oktober 2019.
    1. Fachinformation Dupixent 200 mg Injektionslösung in einer Fertigspritze. Oktober 2019.

Substances